Editor's note - Express Pharma

Lessons from COVID-19

2019-nCoV, nitrosamine issues trigger supply chain re-jigs

2019-nCoV must reform India Pharma Inc

2019-nCoV: A wake-up call

Will Budget 2020 be a salve or a sting for India Pharma Inc?

Why API price needs to be part of NPPA’s pricing formula

Will regulators catch up in 2020?

Rationalising pharma trade margins seems next on the list

Lupin sells stakes in Kyowa but its not a Sayonara

After sartans and ranitidine, where will NDMA show up next?